UB
BEAM icon

UMB Bank’s Beam Therapeutics BEAM Stock Holding History

UMB Bank’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.19K Sell
50
-50
-50% -$1.39K ﹤0.01% 2204
2025
Q4 		$2.77K Hold
100
– – ﹤0.01% 2134
2025
Q3 		$2.43K Buy
+100
New +$1.99K ﹤0.01% 2022
2022
Q3 		– Sell
-52
Closed -$2K – 1758
2022
Q2 		$2K Hold
52
– – ﹤0.01% 1716
2022
Q1 		$3K Hold
52
– – ﹤0.01% 1740
2021
Q4 		$4K Buy
+52
New +$4.45K ﹤0.01% 1669

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

UMB Bank's BEAM Position: Q1 2026 in Review

UMB Bank reduced its Beam Therapeutics (BEAM) stake by 50% in Q1 2026, selling an estimated $1.39K and leaving 50 shares worth $1.19K. The position accounts for ﹤0.01% of the portfolio, ranked #2204.

UMB Bank first reported a position in BEAM in Q4 2021 and has held it in 6 quarters since. The position peaked at $4K in Q4 2021. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • UMB Bank held 50 shares of Beam Therapeutics worth $1.19K as of Q1 2026.
  • UMB Bank sold 50 Beam Therapeutics shares in Q1 2026, an estimated $1.39K.
  • Beam Therapeutics made up ﹤0.01% of UMB Bank's portfolio in Q1 2026, its #2204 holding.
  • UMB Bank first reported a position in Beam Therapeutics in Q4 2021 and has held it in 6 quarters since.
  • UMB Bank's Beam Therapeutics position peaked at $4K in Q4 2021.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on UMB Bank's 13F filing for Q1 2026, filed 11 May 2026.